FDA Approves First New Schizophrenia Drug In Decades
The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades. What do you think?…
